Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Children | 2 |
| Comorbidity | 2 |
| Control Groups | 2 |
| Outcomes of Treatment | 2 |
| Research Methodology | 2 |
| Adolescents | 1 |
| Adults | 1 |
| Attention Deficit… | 1 |
| Autism | 1 |
| Biofeedback | 1 |
| Diagnostic Tests | 1 |
| More ▼ | |
Author
| Arnold, L. Eugene | 1 |
| DeBeus, Roger | 1 |
| Ghaziuddin, Mohammad | 1 |
| Hersch, Sarah | 1 |
| Hurt, Elizabeth | 1 |
| Lofthouse, Nicholas | 1 |
| Mohiuddin, Sarah | 1 |
Publication Type
| Information Analyses | 2 |
| Journal Articles | 2 |
| Reports - Evaluative | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkMohiuddin, Sarah; Ghaziuddin, Mohammad – Autism: The International Journal of Research and Practice, 2013
While there is no cure for autism spectrum disorder, psychopharmacologic agents are often used with behavioral and educational approaches to treat its comorbid symptoms of hyperactivity, irritability, and aggression. Studies suggest that at least 50% of persons with autism spectrum disorder receive psychotropic medications during their life span.…
Descriptors: Autism, Pervasive Developmental Disorders, Drug Therapy, Symptoms (Individual Disorders)
Lofthouse, Nicholas; Arnold, L. Eugene; Hersch, Sarah; Hurt, Elizabeth; DeBeus, Roger – Journal of Attention Disorders, 2012
Objective: The aim of this paper was to review all randomized published trials and unpublished conference presentations on the neurofeedback (NF) treatment of pediatric ADHD, and their relevance, strengths, and limitations. Method: Via PsychInfo and Medline searches and contacts with NF researchers 14 studies were identified and reviewed. Results:…
Descriptors: Identification, Evidence, Outcome Measures, Mental Disorders
